Uti infection
Reading File
Finding Sources
Searching PubMed
"urinary tract infection" AND management
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is a thorough clinical overview of Urinary Tract Infections (UTIs) drawn from authoritative medical textbooks:
Urinary Tract Infection (UTI)
Definition
A UTI is an infection somewhere along the urinary tract that produces clinical symptoms. The mere presence of bacteria in urine without symptoms is called asymptomatic bacteriuria (ASB) - an important distinction because ASB generally does NOT require treatment (exceptions: pregnant patients and pre-urologic procedure patients).
- Cystitis - symptomatic infection of the bladder
- Pyelonephritis - symptomatic infection of the kidneys
- Prostatitis - symptomatic infection of the prostate
- Uncomplicated UTI - confined to the bladder in a patient without a catheter
- Complicated UTI - extends beyond the bladder, or occurs with a catheter, structural/functional abnormality, pregnancy, diabetes, immunosuppression, renal insufficiency, or recent hospitalization
(Harrison's Principles of Internal Medicine, 22E)
Epidemiology
- Up to 80% of women develop at least one UTI during their lifetime
- Between ages 1-50, UTIs are predominantly a female condition
- After age 50, prostatic hypertrophy increases male risk, nearly equalizing incidence
- 20-30% of women with one UTI will have recurrent episodes (avg. 2.6 reinfections/year)
- In the US, the urinary tract is the most common source of infection in septic shock patients, with 10-20% mortality
(Harrison's Principles of Internal Medicine, 22E; Rosen's Emergency Medicine)
Risk Factors
| Category | Examples |
|---|---|
| Impaired urine outflow | Prostatic hypertrophy, cystocele, urinary stones, neurogenic bladder |
| Bacterial entry | Sexual intercourse, urinary catheterization, foreign bodies (stents, stones) |
| Impaired mucosal defenses | Spermicide use, antibiotic-altered flora, postmenopausal estrogen loss |
| Systemic factors | Diabetes, immunosuppression, pregnancy |
Sexual intercourse and spermicide use are the most consistently documented risk factors for recurrent UTI.
Causative Organisms (Etiology)
| Organism | % of Acute Cystitis |
|---|---|
| Escherichia coli | 75-90% |
| Staphylococcus saprophyticus | 5-15% (especially young women) |
| Klebsiella, Proteus, Enterobacter | Majority of remainder |
| Staphylococcus spp. | <10% |
| Pseudomonas aeruginosa, enterococci, Candida | More common in CAUTI |
Important: Antimicrobial resistance is increasing. Resistance to TMP-SMX, fluoroquinolones, and nitrofurantoin now exceeds 20% in some US regions. ~9% of isolates produce extended-spectrum beta-lactamases (ESBL).
(Harrison's 22E; Berek & Novak's Gynecology)
Pathogenesis
The most common route is ascending infection: bacteria ascend from the urethra to the bladder, then (in pyelonephritis) to the ureters and kidneys. Hematogenous spread accounts for <2% of UTIs and is associated with virulent organisms like S. aureus and Salmonella (which, when isolated in urine, should prompt evaluation for concurrent bacteremia).
Key facilitating factors:
- Women have a shorter urethra (~4 cm) than men, facilitating bacterial ascent
- Any foreign body (catheter, stone, stent) serves as a surface for bacterial colonization
- Bacteria form biofilms on catheters that protect them from antibiotics
(Harrison's Principles of Internal Medicine, 22E)
Clinical Features
Lower UTI (Cystitis):
- Dysuria (burning on urination)
- Urinary frequency and urgency
- Suprapubic discomfort
- Hematuria
- Cloudy or foul-smelling urine
Upper UTI (Pyelonephritis):
- All of the above PLUS systemic symptoms
- Fever, chills, malaise
- Flank/costovertebral angle (CVA) pain and tenderness
- Nausea and vomiting
- Right-sided symptoms are more common in pregnancy (mechanical compression of right ureter)
Diagnosis
- Urinalysis: pyuria (WBCs in urine), bacteriuria, possible hematuria
- Urine culture: growth of ≥10⁵ organisms/mL from a voided midstream specimen is diagnostic. Lower colony counts (≥10⁴/mL) of a single enteric gram-negative rod are also strongly suggestive
- Gram stain of uncentrifuged urine: gram-negative rods = indicative of UTI
- Culture is not required for every uncomplicated cystitis episode; it is recommended when the presentation is atypical, for complicated UTI, and for recurrent infections
(Henry's Clinical Diagnosis by Laboratory Methods; Jawetz Medical Microbiology)
Treatment
Uncomplicated Cystitis (First-line agents):
| Drug | Dose/Duration |
|---|---|
| Nitrofurantoin | 100 mg BID x 5 days |
| Fosfomycin | 3 g single oral dose |
| Trimethoprim-sulfamethoxazole | 800/160 mg BID x 3 days (if local resistance <20%) |
Fluoroquinolones (e.g., ciprofloxacin) are NOT recommended as first-line for uncomplicated UTI due to resistance concerns and the need to preserve them for more serious infections. (Rosen's Emergency Medicine)
Pyelonephritis (Outpatient):
- Fluoroquinolone (ciprofloxacin 500 mg PO BID x 7 days, or levofloxacin 750 mg daily x 5 days) if susceptibility confirmed
- Duration: 7-14 days (up to 2 weeks for severe cases)
Pyelonephritis (Inpatient/IV):
- Ceftriaxone 1-2 g IV daily
- Piperacillin-tazobactam 3.375 g IV every 6 hours
- Transition to oral therapy when afebrile and tolerating oral intake
Urosepsis:
- Prompt parenteral empiric antibiotics (piperacillin-tazobactam or ceftriaxone) + supportive care
- Urgent drainage of any obstructing lesion
Complicated UTI with P. aeruginosa:
- Options include ciprofloxacin IV, levofloxacin IV, aminoglycosides (amikacin), antipseudomonal beta-lactams, carbapenems
- For drug-resistant strains: ceftazidime-avibactam or ceftolozane-tazobactam
(Goldman-Cecil Medicine; Rosen's Emergency Medicine)
Special Populations
Pregnancy:
- Screen for ASB at 12-16 weeks (USPSTF grade A recommendation)
- Up to 30% of untreated ASB in pregnancy will progress to pyelonephritis
- Treat with: cephalexin 500 mg BID x 3-7 days; nitrofurantoin 100 mg BID x 3-7 days; amoxicillin 500 mg TID x 7 days; or TMP-SMX BID x 3 days (avoid in 3rd trimester)
- Pyelonephritis in pregnancy: IV ceftriaxone, IV hydration, obstetric consultation
- Antibiotic treatment may also reduce the risk of preterm delivery and low birth weight
(Rosen's Emergency Medicine)
Prophylaxis for Recurrent UTI in Women
| Regimen | Drug Options |
|---|---|
| Long-term low dose | Nitrofurantoin 50-100 mg daily; TMP-SMX 40/200 mg daily or every other day |
| Postcoital (single dose) | Cephalexin 250 mg; TMP-SMX 40/200 mg |
| Other | Cephalexin 250-500 mg daily; norfloxacin 200 mg daily |
Note: Chronic fluoroquinolone prophylaxis is NOT advised due to resistance induction.
(Goldman-Cecil Medicine)
Differential Diagnosis
UTI symptoms can mimic:
- Vaginitis
- Herpes genitalis (external dysuria = burning at perineum)
- Chlamydial urethritis
- Ovarian torsion (lower abdominal/pelvic pain)
- Appendicitis, cholecystitis (for upper tract symptoms)
- Premature labor (flank pain in pregnancy)
Recent Evidence (2024-2026)
A 2024 consensus practice guideline for UTI prevention, diagnosis, and management (JAMA Network Open, PMID 39495518) was published covering both pediatric and adult populations - the most up-to-date reference for current clinical practice. A 2024 network meta-analysis (PMID 39030132) evaluated cranberry-based products for UTI prevention, finding modest benefit for prevention in recurrent cases.
Key takeaways:
- Most UTIs are caused by E. coli and are easily treated with short-course oral antibiotics
- Nitrofurantoin and fosfomycin are preferred first-line agents for uncomplicated cystitis; fluoroquinolones should be reserved
- Antibiotic resistance is a growing problem - always use local antibiogram data to guide empiric therapy
- Asymptomatic bacteriuria should only be treated in pregnancy and pre-urologic procedures
This is a shared conversation. Sign in to Orris to start your own chat.